Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q1 2023)

As of Mar 31, 2023, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on May 12, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2023, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2023
A
Agilent Technologies, Inc.
Buy - Position Entry
+544,200
Q1 2023
AA
Alcoa Corporation
Sell
-439,400
Q1 2023
AAAU
Goldman Sachs Physical Gold ETF
Buy - Position Entry
+94,400
Q1 2023
AADI
Aadi Bioscience, Inc.
Buy
+74,502
Q1 2023
AAL
American Airlines Group, Inc.
Buy
+6,471,132
Q1 2023
Buy - Position Entry
+9,785
Q1 2023
AAME
Atlantic American Corporation
Buy
+400
Q1 2023
AAN
Buy
+236,900
Q1 2023
AAOI
Applied Optoelectronics, Inc.
Buy
+17,800
Q1 2023
AAON
AAON, Inc.
Buy
+57,800
Q1 2023
AAP
Advance Auto Parts Inc.
Buy - Position Entry
+291,750
Q1 2023
AAPL
Apple Inc.
Sell
-7,090,086
Q1 2023
AAT
American Assets Trust, Inc.
Sell
-119,100
Q1 2023
AAXJ
iShares MSCI All Country Asia e
Buy
+100
Q1 2023
ABBNY
ABB Ltd.
Sell
-279,700
Q1 2023
ABBV
AbbVie Inc.
Sell
-15,900
Q1 2023
ABCL
AbCellera Biologics Inc.
Buy
+689,100
Q1 2023
ABEO
Abeona Therapeutics Inc.
Sell
-25,800
Q1 2023
ABEV
Ambev S.A.
Buy
+11,204,526
Q1 2023
ABG
Asbury Automotive Group Inc
Buy - Position Entry
+19,800
Q1 2023
Buy
+4,500
Q1 2023
ABM
ABM Industries Incorporated
Buy - Position Entry
+56,700
Q1 2023
ABNB
Airbnb, Inc.
Sell
-2,548,190
Q1 2023
ABOS
Acumen Pharmaceuticals, Inc.
Buy
+5,145
Q1 2023
ABSI
Absci Corporation
Buy
+194,993
Q1 2023
ABT
Abbott Laboratories
Buy
+1,742,500
Q1 2023
ABUS
Arbutus Biopharma Corporation
Buy
+239,855
Q1 2023
AC
Associated Capital Group, Inc.
Buy
+100
Q1 2023
ACA
Arcosa, Inc.
Sell
-76,600
Q1 2023
ACAD
ACADIA Pharmaceuticals Inc.
Sell
-197,900
Page 1 of 120